NeuroSense Therapeutics Dividends Paid Growth & History (NRSN)
NeuroSense Therapeutics paid $310,000 in dividends during fiscal 2023.
View full NeuroSense Therapeutics company overviewNeuroSense Therapeutics annual dividends paid history
2019
2020
2021
2022
2023
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $310,000 | $0 | 0.00% |
| 2022 | 2022-12-31 | $310,000 | $281,000 | +968.97% |
| 2021 | 2021-12-31 | $29,000 | $1,000 | +3.57% |
| 2020 | 2020-12-31 | $28,000 | $1,000 | +3.70% |
| 2019 | 2019-12-31 | $27,000 | — | — |
NeuroSense Therapeutics dividends paid trends
Between the periods ended 2019-12-31 and 2023-12-31, NeuroSense Therapeutics's dividends paid increased from $27,000 to $310,000, a change of $283,000.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NeuroSense Therapeutics source filings ↗